Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, July 22, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Quest Diagnostics Introduces bioMerieux THxID®-BRAF Test
Wednesday, June 11, 2014
A companion diagnostic to advance precision medicine for melanoma.

New Molecular Biology Tools Drive Efficiency across a Range of Applications
Wednesday, June 11, 2014
New convenience features and rapid protocols leave more time for analysis and discovery.

Genetics Institute Improves Efficiency of Replication & Screening
Thursday, June 05, 2014
The VIAFLO 96 handheld multichannel pipette from INTEGRA has enabled the Institute of Genetics and Development of Rennes to improve the efficiency and speed with which they replicate yeast strain collections and perform genetic screens in 96 well plates.

Agilent Introduces SureSelectQXT Target Enrichment Kits
Wednesday, June 04, 2014
Solution empowers clinical research sequencing with quick workflow, minimal sample input.

Nanobiotix Presents Successful Phase I Results for NBTXR3 at ASCO
Tuesday, June 03, 2014
Final results demonstrate a very good safety, treatment feasibility and promising signs of efficacy in patients with advanced Soft Tissue Sarcomas.

Multiplicom Launches Two New Diagnostic Kits
Tuesday, June 03, 2014
Company aims for strong growth in the rapidly expanding molecular diagnostic market.

OGT to Sell Cytocell Products Direct in North America
Monday, June 02, 2014
The acquisition brings immediate customer benefits.

Nodality Announces Publication of Promising Data in Melanoma in JTM
Friday, May 30, 2014
Nodality's SCNP platform holds strong potential in aiding the development of new cancer and immuno-oncology treatments.

New Cancer Diagnostic Device
Thursday, May 29, 2014
Commercial launch of a new system to improve cancer diagnosis and treatment.

<< 1 2 3 4 5 6 7 >>
Showing Results 21 - 30 of 2493
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv